Chemical Compound

3-Piperidinol, 5-methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-, (2S,3R,5S)-; Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3ss,23ss)-; Veratramine (7CI,8CI); 1H-Benzo[a]fluorene, veratraman-3,23-diol deriv.; (2S,3R,5S)-5-Methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-3-piperidinol; NSC 17821; NSC 23880

CAS Registry Number 60-70-8
3-Piperidinol, 5-methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-, (2S,3R,5S)-; Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3ss,23ss)-; Veratramine (7CI,8CI); 1H-Benzo[a]fluorene, veratraman-3,23-diol deriv.; (2S,3R,5S)-5-Methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-3-piperidinol; NSC 17821; NSC 23880 结构式
Primary record

3-Piperidinol, 5-methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-, (2S,3R,5S)-; Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3ss,23ss)-; Veratramine (7CI,8CI); 1H-Benzo[a]fluorene, veratraman-3,23-diol deriv.; (2S,3R,5S)-5-Methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-3-piperidinol; NSC 17821; NSC 23880

库存
4,917 克
纯度
98.3 %
CAS
60-70-8

化合物标识与属性

CAS
60-70-8
PubChem CID
6070
SMILES
C[C@H]1C[C@H]([C@@H](NC1)[C@@H](C)C2=C(C3=C(C=C2)[C@@H]4CC=C5C[C@H](CC[C@@]5([C@H]4C3)C)O)C)O
Canonical SMILES
Cc1c([C@H](C)[C@@H]2NC[C@@H](C)C[C@H]2O)ccc2c1C[C@H]1[C@H]2CC=C2C[C@@H](O)CC[C@@]21C

名称与同义词

  • VERATRAMINE
  • Vreaframine
  • 60-70-8
  • Veratramine (Standard)
  • NSC 17821
  • AC1L1LQI
  • VERATRAMINE [MI]
  • RefChem:193959
  • NSC 23880
  • C27H39NO2
  • HSDB 3545
  • UNII-RK363YG315
  • CHEBI:9951
  • RK363YG315
  • SCHEMBL335680
  • DTXSID40871534
  • MFCD00468124
  • NSC-17821
  • NSC-23880
  • CHEMBL464724
  • orb1304277
  • NSC17821
  • NSC23880
  • SCHEMBL29352403
  • HY-N0837R
  • BRN 0055515
  • CID6070
  • DTXCID501474790
  • GLXC-02990
  • NSC17821;NSC23880
  • HY-N0837
  • ZINC3875407
  • BDBM50396007
  • C27-H39-N-O2
  • MSK169043
  • NP0597
  • s3911
  • AKOS030526858
  • (3beta,23beta)-14,15,16,17-Tetradehydroveratraman-3,23-diol
  • ACN-035849
  • CCG-268761
  • CS-3005
  • EBC-609484
  • FV28689
  • J4.805D
  • LS-162032
  • AC-33967
  • BS-17189
  • BCP0726000092
  • FT-0776848
  • V0148
  • X0088
  • 5-21-05-00297 (Beilstein Handbook Reference)
  • C10829
  • (3beta,23R)-14,15,16,17-tetradehydroveratraman-3,23-diol
  • 14,15,16,17-Tetradehydroveratraman-3,23-diol
  • A868905
  • Q15427945
  • Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3beta,23beta)-
  • (2S,3R,5S)-2-((S)-1-((3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-2,3,4,6,6a,11,11a,11b-octahydro-1H-benzo[a]fluoren-9-yl)ethyl)-5-methylpiperidin-3-ol
  • (2S,3R,5S)-2-[(1S)-1-[(3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-1,2,3,4,6,6a,11,11a-octahydrobenzo[a]fluoren-9-yl]ethyl]-5-methylpiperidin-3-ol
  • 14,15,16,17-Tetradehydroveratraman-3beta,23beta-diol
  • Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3-beta,23-beta)-
  • (3b,23b)-14,15,16,17-Teradehydroveratraman-3,23-diol
  • (23R)-14,15,16,17-Tetradehydroveratraman-3beta,23-diol
  • (3|A,23|A)-14,15,16,17-Teradehydroveratraman-3,23-diol
  • (3 beta,23 beta)-14,15,16,17-tetradehydroveratraman-3,23-diol
  • (3-beta,23-beta)-14,15,16,17-Tetradehydroveratraman-3,23-diol
  • (3beta,23beta)-14,15,16,17-Teradehydroveratraman-3,23-diol
  • Veratraman-3, 14,15,16,17-tetradehydro-, (3.beta.,23.beta.)-
  • WLN: L D6 B566 LU&TTTJ A1 E1 OQ FY1&- BT6MTJ CQ E1
  • (2S,3R,5S)-2-[(1S)-1-[(3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-1,2,3,4,6,6a,11,11a-octahydrobenzo[a]fluoren-9-yl]ethyl]-5-methyl-piperidin-3-ol
  • (2S,3R,5S)-2-[(1S)-1-[(3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-1H,2H,3H,4H,6H,6aH,11H,11aH,11bH-cyclohexa[a]fluoren-9-yl]ethyl]-5-methylpiperidin-3-ol
  • Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3|A,23|A)-
  • (2S,3R,5S)-2-((1S)-1-((1S,2R,5S,10R)-5-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,16)heptadeca-7,11(16),12,14-tetraen-14-yl)ethyl)-5-methylpiperidin-3-ol
  • 3-PIPERIDINOL, 5-METHYL-2-((1S)-1-((3S,6AR,11AS,11BR)-2,3,4,6,6A,11,11A,11B-OCTAHYDRO-3-HYDROXY-10,11B-DIMETHYL-1H-BENZO(A)FLUOREN-9-YL)ETHYL)-, (2S,3R,5S)-
  • 3-Piperidinol, 5-methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-, (2S,3R,5S)-; Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3ss,23ss)-; Veratramine (7CI,8CI); 1H-Benzo[a]fluorene, veratraman-3,23-diol deriv.; (2S,3R,5S)-5-Methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-3-piperidinol; NSC 17821; NSC 23880
  • 3-Piperidinol,5-methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-,(2S,3R,5S)-